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Abstract Ethyl glucuronide (EtG) and ethyl sulfate (EtS)
are direct alcohol consumption markers widely used nowa-
days for clinical and forensic applications. They are detecta-
ble in blood and urine even after consumption of trace
amounts of ethanol and for a longer time frame, being
detectable even when no more ethanol is present. The insta-
bility of EtG against bacterial degradation in contaminated
urine samples and/or the possible postcollection synthesis of
this metabolite in samples containing, e.g., Escherichia coli
and ethanol, may cause false identification of alcohol up-
take. Therefore, it is of paramount importance to constrict
these error sources by inhibition of any bacterial growth
causing hydrolization or synthesis of EtG. This study eva-
luates a new method of collecting urine samples on filter
paper, dried urine spots (DUS), for simultaneous detection
of EtG, EtS and creatinine, having the great advantage of
inhibiting bacterial activity. In addition, a method validation
for the determination of EtG and EtS in DUS was performed
according to the FDA guidelines. Sterile-filtered urine was
spiked with EtG and EtS, inoculated with E. coli and incu-
bated. Liquid and dried urine samples were collected after
various time intervals up to 96 h. Liquid samples were
frozen immediately after collection, whereas aliquots for
DUS were pipetted onto filter paper, allowed to dry and
stored at RT until analysis 1 week after. The specimens were
analyzed by LC–ESI–MS/MS. As expected, degradation of
EtG, but not of EtS, was observed in contaminated liquid
urine samples. However, the specimens collected on filter
paper and stored at RT showed no degradation during stor-
age. Therefore, collecting urine samples on filter paper for
EtG and EtS analysis turns out to be a reliable method to
avoid bacterial degradation of EtG and EtS, and consequent-
ly, stabilization of these ethanol metabolites is achieved. In
addition, simultaneous measurement of creatinine content as
an indicator of urine dilution helps to interpret the results.
Method validation for EtG and EtS in DUS was satisfactory,
showing the linearity of the calibration curves in the studied
concentration range, good precision, accuracy and
selectivity.
Keywords Ethyl glucuronide (EtG) . Ethyl sulfate (EtS) .
Bacterial degradation . Dried urine spot (DUS) . Creatinine .
LC–ESI–MS/MS
Introduction
The body has different ways to inactivate and excrete exo-
genous substances such as alcohol. Most of the consumed
ethanol is oxidized by alcohol dehydrogenase (ADH) to
acetaldehyde and by aldehyde dehydrogenase (ALDH) to
acetic acid in a phase I metabolism [1, 2]. The two-stage
oxidation represents a fast elimination step in the liver, so
the time gap to detect ethanol in breath, blood or urine is
limited to a short period of time, variable depending on the
consumed amount of alcohol [3, 4]. For abstinence moni-
toring, the focus on more sensitive biomarkers with a longer
detection window has increased over the years [5].
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The most important biological markers for abstinence
control with urine samples are ethyl glucuronide (EtG) [6, 7]
and ethyl sulfate (EtS) [8, 9]. EtG and EtS are formed shortly
after starting the consumption of ethanol by a nonoxidative
elimination pathway, catalyzed by uridine diphosphate-
glucuronosyltransferase [10] or sulfotransferase [11], respec-
tively, being less than 0.1% of the ethanol intake excreted
through this phase II metabolism [4]. Already after the con-
sumption of very small amounts of alcohol, EtG and EtS are
detectable in blood and urine [12, 13] and are still present after
the ethanol has been eliminated [3, 14]. The detection window
of these biomarkers is dose- and individual-dependent [15, 16]
and ranges between 1 to 3 days after alcohol uptake, covering
the time gap between short-term (e.g., ethanol) and long-term
alcohol markers (e.g., GGT, CDT) [17]. Analysis of EtG and
EtS is, therefore, a well-suited method for detection of recent
alcohol consumption, being widely utilized in alcohol absti-
nence programs, in workplace alcohol testing or as proof of
alcohol uptake by court [18, 19].
However, the risk of the presence of bacteria in urine that
might hydrolyze or synthesize EtG and cause false identifi-
cation of alcohol consumption detracts from the credibility
of the method. As reported in the literature [20, 21], bacteria
present in urine samples due to urinary tract infections (UTI)
or contamination during sampling may cause degradation of
EtG leading, thus, to lower EtG concentrations or even to
false-negative results. In addition, it has also been observed
that EtG can be formed in a biological specimen after
collection, if it is infected with Escherichia coli (bacteria
containing β-glucuronidase activity) and ethanol is present
or produced during storage [22]. Although refrigeration or
freezing of samples and the use of different preservatives are
effective in preventing or reducing hydrolysis and/or syn-
thesis of EtG [23], it is common that many urine samples for
EtG and EtS determination are transported at ambient tem-
peratures before analysis and the use of preservatives is not
an extended use due to economic and safety reasons (addi-
tives might disturb analysis of other compounds).
So far, no decomposition or postsampling formation of
EtS by bacteria has been observed [20–22]. This stability
and the similar detection window and sensitivity of EtS with
respect to EtG [9] have made the simultaneous analysis of
these two biomarkers recommendable in order to avoid
undetected alcohol use or to distinguish ante mortem inges-
tion of ethanol from postmortem synthesis in forensic tox-
icological analysis [22].
Recently, the detection of different alcohol markers such
as EtG and phosphatidyl ethanol (PEth) on dried blood and
dried blood spots (DBS), respectively, have been reported
[24–26]. DBS is an established method in neonatal meta-
bolic screening and has also found acceptance in therapeutic
drug monitoring [27]. The ease and rapid collection of a
sample without specific handling and storage requirements
are the main characteristics of this sampling technique.
Besides, specimens can be shipped in sealed envelopes with
desiccant packs without the need of special biohazard
arrangements, resulting in a cost-effective and simple sam-
pling method [28]. It is well-known that analytes in DBS are
less prone to hydrolysis due to the absence of water mole-
cules [29, 30]. In general, analytes studied in DBS are
reported to be fairly stable [27]. However, the use of dried
urine spots (DUS) has not yet been studied for the analysis
of drugs.
The aim of the present study was to investigate if collection
of urine samples on filter paper is a feasible method for
detection and quantification of EtG and EtS and if this sam-
pling method stabilized EtG against bacterial activity. This
was achieved by analyzing urine spiked with E. coli in the
form of DUSs after storage for up to 7 days. The respective
liquid urine samples were analyzed for comparison.
In addition, a method validation for the determination of
EtG and EtS in DUS was performed according to the FDA
guidelines [31]. Method validation included the evaluation
of linearity, accuracy and precision, selectivity, dilution of
concentrated sample, recovery and stability.
Experimental
Chemicals and materials
EtG and pentadeuterated EtG (D5-EtG) were obtained from
Lipomed (Arlesheim, Switzerland). Sodium EtS was pur-
chased from ABCR (Karlsruhe, Germany). Deuterated EtS
(D5-EtS) was synthesized by an in-house procedure with a
purity of >99.9%. Creatinine and trideuterated creatinine were
purchased from Fluka Sigma Aldrich (Buchs, Switzerland).
Acetonitrile supragradient grade was obtained from Biosolve
(Chemie Brunschwig, Basel, Switzerland) and HPLC-grade
water was produced in-house with a Milli-Q water system
from Millipore (Billerica, USA). Formic acid (puriss p.a.,
98%) and methanol (spectrophotometric grade, ≥99%) were
purchased from Fluka Sigma Aldrich (Buchs, Switzerland).
HPLC-grade 2-propanol was purchased from Merck (Darm-
stadt, Germany). Nonbleeding pH indicator strips obtained
from Merck (Darmstadt, Germany) and filter paper What-
mann 903 (formely Schleicher and Schuell 903) (GE Health-
care, Dassel, Germany) as size A4 sheets, cut into 5-mm wide
strips, were used for pipetting of urine samples.
Urinary creatinine content was determined by a Roche
Hitachi 902 (Roche Diagnostics, Mannheim, Germany) ana-
lyzer using the Jaffé picric acid reaction (DRI® Creatinine-
Detect® Test, Microgenics, Passau, Germany). E. coli was
isolated from autopsy material (liver, heart blood, urine,
ascites, pericardial fluid and pleural fluid) (strain no. 9478)
and used for spiking of the urine after it had been sterile-
2418 A. Hernández Redondo et al.
filtered using a Millipore Millex Syringe-Driven Filter Unit
with a 0.22-μm PSE-Membran (SLGP033RS). This mem-
brane filter is typically used for laboratory applications
including sterile filtration of protein solutions, tissue culture
media, additives, buffers and water. This single-use filter
unit consists of a membrane filter sealed in an acrylic
housing and is nonpyrogenic and nontoxic. The Millex filter
unit is compatible with most aqueous solutions and can also
be used for pharmacy admixture application. Drug-free
urine was obtained from a volunteer who was abstinent from
alcohol for at least 1 week.
Preparation of calibration and quality control samples
For spiking calibration samples, working solutions ranging
from 2.5 μg/ml to 250 μg/ml for EtG and EtS and from
1,250 μg/ml to 62,500 μg/ml for creatinine were prepared in
methanol. The stock solution of creatinine was prepared in a
mixture of methanol/formic acid (75/25, v/v). The acidic con-
ditions were necessary to increase the solubility of creatinine
in methanol. For spiking quality control samples, working
solutions with EtG and EtS concentrations of 2.0, 6.0, 40
and 160 μg/mL were prepared in methanol. Calibration sam-
ples for the stability experiment were prepared in water in
order to be able to calibrate also for creatinine. They were
spiked at concentration levels of 0.1, 0.2, 1.0, 2.5, 5.0 and
10 μg/ml for EtG and EtS, and 50, 100, 200, 500, 1,250,
2,500 μg/ml for creatinine.
Experimental set-up
Blank urine was centrifuged (10 min, 1,780g) and sterile-
filtered to remove any bacteria. The sterile urine (9 ml) was
then spiked with EtG and EtS to a final concentration of
approximately 5 μg/ml and optionally with E. coli (1 ml of a
solution with approximately 108 colony forming units
(CFU)/ml) and glucose (10 mg/l), as a further source of
carbon:
Culture I: urine spiked with EtG and EtS and E. coli.
Culture II: urine spiked with EtG and EtS, E. coli and
glucose.
Control sample: urine spiked with EtG and EtS.
The cultures and the control sample (10 mL) were incubated
on an incubator for 5 days at 37 °C. Aliquots were collected at
different time intervals (0, 2, 4.5, 22, 28, 48, 72 and 96 h).
Three samples were collected from each culture tube each
time: a liquid sample (immediately frozen at −25 °C) and
two aliquots collected on a pH indicator strip and on a What-
man 903 filter paper strip. The urine spots were allowed to dry
for 4 h at room temperature and were then stored at room
temperature. To monitor the bacterial growth, Columbia blood
agar plates were prepared and incubated under aerobic con-
ditions with 5% CO2 until examination at each sampling time.
Dried urine spot sample preparation procedure
and extraction
For each sample, 30 μl of spiked water (calibrator) or urine
were pipetted onto filter paper (pH indicator strip and What-
man 903 filter paper strip) and allowed to diffuse and dry for at
least 4 h at ambient room temperature. The specimens from
the stability experiment were then stored in plastic tubes
(2.0 ml, Sarstedt, Nümbrecht, Germany) at room temperature
for 7 days prior to analysis, whereas the specimens for the
validation were analyzed immediately. The filter paper from
the stripes were then cut into smaller pieces and transferred to
microtubes, where they were extracted by vortex mixing for
10 minutes with 300 μl of a methanol solution containing
deuterated standards (0.05 μg/mL D5-EtG, 3 μL of a 1:10
6
dilution of synthesized D5-EtS and 50 μg/mL D3-creatinine).
After centrifugation (10 min, 18,320 g), 150 μl of the solution
was transferred into glass vials with insert (0.5 ml Infochroma,
Zug, Switzerland) and dried under a gentle stream of nitrogen
at 50 °C. Samples were then reconstituted by adding 50μl of a
water/acetonitrile/formic acid (95/5/0.1; v/v) solution and
shaken for 1 min. Ten microliters was injected into the LC–
MS/MS system.
Processing of liquid urine samples
For each liquid sample, 50 μl of spiked water (calibrator) or
urine was pipetted into a microtube. The liquid urine samples
collected at different time intervals were frozen immediately
after collection until analysis. All samples were extracted by
vortex mixing for 10 min with 150 μl of an acetonitrile
solution containing deuterated standards (0.1 μg/ml D5-EtG,
6 μl of a 1:106 dilution of synthesized D5-EtS and 100 μg/ml
D3-creatinine). After centrifugation (10 min, 18,320 g), 100 μl
of the supernatant solution was transferred into glass vials and
dried under a gentle stream of nitrogen at 50 °C. Samples were
then reconstituted by adding 100 μl of a water/acetonitrile/
formic acid (95/5/0.1; v/v) solution and shaken for 1 min. Ten
microliters was injected into the LC–MS/MS system. The
creatinine content of liquid urine samples was measured by
LC–MS/MS and then also by a Roche Hitachi 912 analyzer
using the DRI creatinine kit (Microgenics, Passau, Germany)
for comparison of the results.
Quantification of the colony forming units (CFU)
Serial dilutions (10−1–10−6) of cultures I and II were pre-
pared in a 0.9% NaCl solution each sampling time. One
hundred microliters of the diluted samples (10−6,10−5) and
20 μL of the control sample were plated on a Columbia
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blood agar plate and incubated at 37 °C. The agar plates
were examined for bacterial growth after 24 h.
Validation
A validation method for the determination of EtG and EtS in
DUS was performed according to the guidelines of the FDA
[31]. During the validation, all samples were processed as
DUS, as described before. The parameters evaluated were
linearity, accuracy and precision, selectivity, dilution of
concentrated sample, recovery and stability. Precision was
expressed as the relative standard deviation (RSD%). Accu-
racy was expressed as the mean relative error (RE%).
Calibration and quality control samples were prepared by
spiking blank urine with the above described working so-
lutions. Six-point calibration curves with EtG and EtS con-
centrations of 0.1, 0.2, 1.0, 2.5, 5.0 and 10 μg/ml were
prepared in duplicate on three different days, pipetted onto
pH indicator strips, allowed to dry and analyzed. Precision
and accuracy were determined by preparing DUS from urine
spiked at different EtG and EtS concentration levels and
defined as quality controls (QC): 0.1 μg/ml, 0.3 μg/ml
(QClow), 2.0 μg/ml (QCmiddle) and 8.0 μg/ml (QChigh). The
lowest QC level had the same concentration as the first
calibrator. Intraday precision was determined by replicate
analysis (n06) of spiked samples at these four concentration
levels; interday precision was assessed by analysis of spiked
samples on 3 days.
The selectivity of the method was evaluated by analyzing
blank urine from six different sources and tested for inter-
ference from endogenous matrix components, metabolites,
decomposition products, etc. Possible dilution of samples
with concentrations over the calibration range was studied
by preparing DUS with EtG and EtS concentrations ten
times the highest QC level (80 μg/ml). The methanolic
extracts containing the analytes and the internal standards
were then diluted before reconstitution. Finally, 150 μl of
the diluted solution was evaporated and reconstituted by
adding 50 μl of a water/acetonitrile/formic acid (95/5/0.1;
v/v) solution. After the LC–MS/MS analysis, the results
were corrected for the dilution factor.
In order to determine the recovery of EtG and EtS from
DUS, DUS were created with blank urine and extracted as
usual with methanol containing internal standards. Before
evaporation and reconstitution, 150 μL of the extracts was
spiked with 30 μl of the appropriated QC working solution
(six replicates at QClow, QCmiddle and QChigh). The recovery
was assessed by comparing the analyte/internal standard peak
area ratio of these unextracted samples with that of extracted
samples spiked at the same EtG and EtS concentrations.
The stability of EtG and EtS in DUS was investigated by
storing specimens at different conditions. Therefore, DUS
were prepared at both low (0.3 μg/ml) and high (8.0 μg/ml)
concentration levels and stored in plastic sealable bags at
room temperature and at 4 °C for 1, 2 and 3 weeks. Six
replicates (n06) of each concentration level were analyzed
after each time period. On the other hand, to assess the
stability of already processed samples, extracts (six repli-
cates at four different concentration levels: 0.1, 0.3, 2.0 and
8.0 μg/ml) were reinjected after 7 days at 4 °C.
Chromatographic system
Instrumentation consisted of a CTC PAL autosampler, an
Agilent 1200 series HPLC and a QTrap 3200 mass spec-
trometer (AB Sciex, Rotkreuz, Switzerland) controlled by
Analyst 1.5.1 software, which was also used for the data
acquisition and processing. For the analytical separation, a
150×2 mm column with 4 μm particles (Synergi Polar-RP,
Phenomenex, Torrance CA, USA) contained in a column
heater at 40 °C was used. To enhance signal intensity, 2-
propanol was added postcolumn with a flow of 0.3 ml/min
by a T-union before the eluent enters the electrospray ion
source.
The gradient elution was performed with 0.1% formic
acid in water as mobile phase A and 0.1% formic acid in
acetonitrile as mobile phase B. The gradient was run at a
flow of 0.3 ml/min, starting at 2% B for 2 min and increasing
to 90% B for 3 min. The gradient was then changed back to
the starting conditions over 0.5 min and kept constant for
6.5 min to re-equilibrate. The retention times of EtG, EtS and
creatinine were 1.92, 1.68 and 1.57 min, respectively.
The mass spectrometer was operated in the negative
multiple reaction monitoring (MRM) mode by employing
a TurboIonSpray source. The following transitions (quantifier,
qualifier and internal standard) and parameters (DP, CE) were
used: EtG: m/z 221/75, m/z 221/85, m/z 226/75, DP: −28 V,
CE: −24 V; EtS: m/z 125/97, m/z 125/80, m/z 130/98, −30 V,
−25 V; creatinine: m/z 112/68, m/z 115/68 (IS), −35 V, −25 V.
For the EtS qualifier transition, a DP of −50 V and a CE of
−44 V were used.
Results and discussion
It has been reported, that some pathogens that cause urinary
tract infections (UTIs) can hydrolyze or synthesize EtG
[20–22], but it is not known that EtS is sensitive to bacterial
degradation.E. coli is the predominant bacteria found in UTIs,
with most strains presenting a β-glucuronidase activity that
cleaves glucuronide conjugates such as EtG [21]. This study
was designed to test whether spotting on paper and drying
could hinder EtG and EtS degradation in urine contaminated
with E. coli. The EtG and EtS concentrations, unlike ethanol,
are known to be influenced by urine dilution [2, 4]. For this
reason,measurement of the creatinine content of the investigated
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urine is necessary. In our laboratory, creatinine is regularly
measured by a spectrophotometric test with liquid urine sam-
ples. In our investigation, however, we worked with DUSs.
Therefore, the possibility of extracting and measuring creatinine
together with the two studied alcohol markers by an LC–ESI–
MS/MS method was investigated.
Stability experiment
The two cultures (I and II) used for the stability test con-
sisted of sterile urine spiked with EtG and EtS to a final
concentration of approximately 5 μg/ml and (I) E. coli
(approximately 106 CFU); (II) E. coli (approximately
106 CFU) and glucose (10 mg/l), as a further source of
carbon. Sterile urine spiked with EtG and EtS at the same
concentration as the two cultures studied was used as control
sample and incubated on an incubator for 5 days at 37 °C,
together with cultures I and II.
The degradation of EtG and EtS in urine was followed-up
for up to 4 days. Aliquots were collected at different time
intervals: 0, 2, 4.5, 22, 28, 48, 72 and 96 h. Liquid samples
were directly frozen after sampling, whereas aliquots for
DUS were pipetted onto a pH indicator strip from Merck
and onto Whatman 903 filter paper, in order to compare
both types of absorbent papers. The DUSs were allowed to
dry and stored in plastic tubes for 7 days at room tempera-
ture. After this time, liquid samples were thawed and pro-
cessed as described before together with a freshly made
calibration curve in water. Simultaneously, samples collected
as DUSs were also processed as required and two different
calibration curves in water were made, one for the pH indica-
tor strip samples and another one for the Whatman 903 filter
paper samples. The three-calibration curves were prepared in
water, in order to be able to calibrate creatinine, which is
present in urine. The results are shown in Fig. 1.
In agreement with literature reports [20, 21], a degrada-
tion of EtG in cultures I (see Fig. 1a) and II (see Fig. 1b) due
to bacterial activity was observed during the studied time
period: after 4.5 h, 60% of the EtG had been hydrolyzed.
Aliquots of cultures I and II, collected and stored for 7 days
at room temperature as DUS before analysis showed the
same concentrations for both alcohol markers as the liquid
samples; no further degradation was observed after collec-
tion as DUSs (see Fig. 2). This means, DUSs containing E.
coli and stored for 7 days at room temperature showed no
degradation of EtG during storage, but the same biomarker
concentration as the liquid sample collected at the same time
and stored refrigerated to prevent hydrolysis. By drying the
contaminated urine samples on filter paper, bacterial growth
was inhibited and, consequently, EtG was stabilized against
bacterial hydrolysis. The same results were observed in
DUSs collected on pH indicator strips and on Whatman
903 filter paper.
In addition, no difference in the degradation rate of EtG
was observed between cultures I and II (see Fig. 1a and b).
This means, that the presence of glucose in the latter did not
influence the hydrolysis of EtG by E. coli. In comparison
with the results of Baranowski et al. [21], where EtG was
totally degraded after 96 h, in our experiments, it took only
22 h. This can be explained by the higher concentration of
bacteria in the presented study.
The EtS concentration did not change during the experi-
ment (96 h at 37 °C) in cultures I and II, neither in the liquid
Fig. 1 EtG (black), EtS (blue) and creatinine (red) concentration in
cultures I (a) and II (b) and in the control sample (c) in the different
collection modes: liquid urine samples (rhombus with dashed line), pH
indicator strips (triangle with dotted line) and Whatman 903 filter
paper (square with solid line)
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samples nor in any of the two kinds of DUSs (see Fig. 1a and
b), confirming previous observations about the stability of this
alcohol metabolite during incubation with E. coli. The creat-
inine concentration did not vary either during the test and was
in agreement with the concentrations measured with the spec-
trophotometric test (results not shown in detail). As expected
due to the lack of ethanol in the urine samples, no EtG or EtS
formation could be observed in any of the cultures studied, as
it was the case in the experiments of Helander et al. [22].
Validation
The linearity of the calibration range was evaluated by
analyzing DUS created from urine spiked at EtG and EtS
concentration levels of 0.1, 0.2, 1.0, 2.5, 5.0 and 10 μg/mL.
The calibration curve was analyzed in duplicate over three
different days. A least squares regression algorithm with
mean regression coefficients of 0.9981 and 0.9984 for EtG
and EtS, respectively, best determined the linearity of the
method in the studied calibration range. The limits of detec-
tion (LOD) and limits of quantitation (LOQ) were deter-
mined using a linear regression model according to ISO
32645 guidelines with a calibration range from 0 to
1.0 μg/mL. The LOD and LOQ were 0.050 μg/ml and
0.175 μg/ml for EtG, and 0.100 μg/ml and 0.340 μg/ml
for EtS, respectively.
Precision and accuracy were determined by preparing
DUS from urine spiked at EtG and EtS concentration levels
of 0.1 μg/ml, 0.3 μg/ml (QClow), 2.0 μg/ml (QCmiddle) and
8.0 μg/l (QChigh). Intra- and interday assay variations were
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Fig. 2 Ion chromatograms of
DUSs from culture I collected
at the beginning of the
experiment (t00) and stored
at RT for 7 days until analysis:
a pH filter strip; b Whatman
903 filter paper
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determined by analyzing replicate samples (n06) of each
QC level on three different days. For both intra- and inter-
day assays, precision and accuracy of EtG and EtS were
always less than 15%, or 20% in the case of the QC level
with the lowest concentration. Precision and accuracy data
are summarized in Table 1.
The selectivity of the method was evaluated by analyzing
DUS created with urine from six different sources and
compared with urine spiked at EtG and EtS concentrations
of 0.1 μg/ml. No interfering substances could be observed in
any of the DUS analyzed for any of the ethanol metabolites
studied, being, therefore, the selectivity ensured at the lowest
calibration level.
In addition, the possibility of diluting a sample with EtG
and EtS concentrations over the calibration range was studied
during the validation. For this purpose, six DUS replicates
(n06) were created with blank urine spiked at EtG and EtS
concentrations ten times higher than QChigh, 80 μg/ml.
Following a tenfold dilution of the methanolic extracts,
samples were injected into the LC–MS/MS system. The
concentrations were back-calculated taking into consideration
the dilution factor. Precision and accuracy were found to be
within the acceptance limits of 15%.
The extraction efficiency of EtG and EtS from DUS was
evaluated by analyzing DUS spiked with the analytes at
three different concentrations: 0.3, 2.0 and 8.0 μg/ml. Six
replicates (n06) at each concentration level were extracted
and analyzed, and the analyte/internal standard peak area
ratios were compared with those of nonextracted DUS cre-
ated with blank urine and spiked with EtG and EtS after the
extraction to concentrations which represent 100% recovery.
The recovery for EtG and EtS was always higher than 32%
and 38%, respectively, and it was reproducible over the
calibration range.
The stability of EtG and EtS in DUS was investigated by
preparing specimens at two different concentration levels,
QClow and QChigh, and by storing them in sealable plastic
bags at room temperature (RT) and at 4 °C for 1, 2 and
3 weeks. After these time periods, six replicates (n06) of
each concentration level stored at room temperature and at
4 °C were processed and analyzed. The results shown in
Table 2 demonstrate that both analytes are stable at RT and
at 4 °C for at least 1 week. After this time, their stability
decreased.
Reinjection of already processed samples after 7-day
storage at 4 °C was performed with six replicates (n06)
from each QC level: 0.1, 0.3, 2.0 and 8.0 μg/ml. In these
reinjected samples, precision and accuracy for EtG and EtS
were always less than 15%, except for EtG at QChigh, where
the accuracy was 17.5%.
Conclusion
In this study with dried urine spots (DUS), an innovative
method for sample collection and subsequent simultaneous
determination of EtG, EtS and creatinine in urine by LC–
ESI–MS/MS is presented. The method proved to be not only
reliable for the determination of these analytes but it can
also be recommended due to the inhibition of degradation of
EtG by E. coli observed in traditionally used liquid urine
specimens.
Bacterial growth, necessary for bacterial degradation of
analytes, was inhibited upon drying the contaminated urine
specimens on filter paper. In this way, no hydrolysis of EtG
took place, even upon storage of the samples at room
temperature, eliminating thus the risk of having lower con-
centrations or even false-negative identification of EtG. EtS
was also stable on DUSs containing E. coli, confirming thus
the reported stability of this metabolite against bacterial
degradation. Other pathogens such as Clostridium sordellii
[21] or Klebsiella pneumonia [20] that are reported to hy-
drolyze EtG, were not studied in this experiment. However,
Table 1 Precision (RSD%) and accuracy (RE%) of the EtG and EtS analysis in DUS
Nominal conc (μg/ml) Intraday (n06) EtG Interday (n03) EtG Intraday (n06) EtS Interday (n03) EtS
Precision Accuracy Precision Accuracy Precision Accuracy Precision Accuracy
0.1 10.4 6.0 13.7 2.0 2.5 18.0 9.6 14.0
0.3 5.2 9.0 5.0 6.3 3.6 10.7 6.4 10.0
2.0 5.7 6.0 4.1 8.5 3.2 8.0 4.2 7.5
8.0 6.7 11.3 6.7 12.5 7.0 7.5 5.6 11.3
Table 2 Stability of EtG and EtS in DUS over 3 weeks at room
temperature (RT) and at 4 °C expressed as mean relative error (RE%)
Nominal conc.
(μg/ml) (n06)
1 week 2 weeks 3 weeks
RT 4 °C RT 4 °C RT 4 °C
EtG 0.3 5.1 6.3 −5.8 −2.6 17.2 10.0
8.0 11.0 15.5 22.3 30.0 16.7 7.6
EtS 0.3 1.4 1.9 2.3 10.5 12.6 17.4
8.0 3.0 10.3 20.0 17.4 19.1 13.7
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the results presented here lead us to think that EtG is stable
against any bacterial degradation, since dehydration of the
specimens hinders the growth of pathogens.
The simultaneous extraction and determination of creati-
nine, EtG and EtS from DUSs disregards the need for liquid
urine samples, thus facilitating transport and storage of
specimens, since there is no need to freeze samples to hinder
bacterial degradation.
The DUS method is, thus, highly recommended for EtG
and EtS determination in urine samples because it is con-
sidered that with this sampling and collection method, a
further step in the reliability of EtG and EtS analysis for
detection of alcohol consumption can be done.
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